Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y1DR
|
|||
| Former ID |
DNC010263
|
|||
| Drug Name |
4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine
|
|||
| Synonyms |
CHEMBL611630; 4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H16N6O
|
|||
| Canonical SMILES |
C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC5=C(C=C4)C=CN5
|
|||
| InChI |
1S/C17H16N6O/c1-2-12(9-13-11(1)3-4-18-13)15-21-16-14(19-10-20-16)17(22-15)23-5-7-24-8-6-23/h1-4,9-10,18H,5-8H2,(H,19,20,21,22)
|
|||
| InChIKey |
LYJKHCYTQHFQLX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-alpha: Hit to lead studies. Bioorg Med Chem Lett. 2010 Jan 15;20(2):636-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.